Randomized trial develops and validates an analytical method for Olanzapine and Samidorphan, highlighting its reliability for pharmaceutical use.
AIM: The main aim of the present study is to develop an accurate, precise, sensitive, selective, reproducible and rapid analytical technique for simultaneous estimation of Olanzapine– Samidorphan in bulk and pharmaceutical dosage form. The proposed method will be validated in accordance with regulatory guidelines to ensure its reliability and robustness for routine quality control analysis. Furthermore, the method aims to demonstrate good linearity, specificity, and stability-indicating capability under various stress conditions. This study also seeks to provide a cost-effective and time-efficient approach suitable for pharmaceutical industries and research laboratories.
No takes yet. Share an insight, caveat, or question.
Sagili Varalaxmi* (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: